Monday, December 22, 2014
MUMBAI: In a rare operation, doctors of a city-based hospital has successfully removed a 12 kg tumour from the abdomen of a 37-year-old woman.
Doctors at Global Hospital in Parel area, where the surgery was conducted on December 5, said that the woman, who lives in Central suburbs of the city, complained of a stiff and a continuous bloating stomach for the last 6 months. She however, never experienced any pain.
"Around 6 months back, she felt her stomach was growing but she did not have any pain or discomfort. Her family doctor got an Ultra Sound (test) done which picked up a large tumour. Subsequently, we did a CT and an MRI scan and that is how we came to the conclusion that she had Liposarcoma," Dr Nimesh Shah, Consultant General surgeon at Global hospital said. He added that the tumour, which was cancerous, would have ultimately resulted in the death of the woman, had it been not removed on time.
"We were aware even prior to the surgery that we were dealing with a cancerous tumour. If this tumour was not removed on time, she could have suffered from bowel complications, involvement of major blood vessels or probably one kidney not functioning," Dr Jignesh Gandhi, a consultant surgeon, who was also a part of the surgery, said.
The operation lasted for around four hours and required four bottles of blood for transfusion. "This is a very rare case. The incidence rate is 1-1.5 in a million people. If the tumour had been left inside the body, it could have affected the liver, lungs and brain," Gandhi added.
Dr Shah said that the woman has been discharged today and will now be in the care of a chemo-therapist, who will give her radiation treatment to remove residuals of the malignant tumour.
"We will keep on radiating here. We have removed the tumour but microscopically, residuals may have been left behind. The chemo therapist will take a call whether an oral tablet can also be given to her," he said.
Gandhi said that any sudden and abnormal changes in the body should not be taken lightly and a timely advise from a doctor can help detect and treat such problems at an early stage.
BENGALURU: This 10-year-old cancer patient from Sri Lanka has his limb remote-controlled. To ensure that he doesn't undergo surgical procedures often, doctors have increased the length of the magnetic metallic implant on his left leg through remote-control. The implant was placed after a cancerous tumour was removed from his knee.
Binura Lakvindu from Colombo, who was diagnosed with bone cancer, underwent surgery at BGS Global Hospital, Bengaluru, recently.
"For Binura, we have implanted the expandable prosthesis that has an in-built magnetic disc, gear box and a telescoping rod. The growth anticipated from that bone was calculated and the prosthesis was designed accordingly. He has to visit the hospital once in three months and place his leg in a magnetic coil, and the limb will be lengthened by 1 mm in 4 minutes. The required length will be achieved without additional surgeries. Binura will have limb growth up to 14 to 15 years," said explains Dr Srinivas C H, consultant, orthopaedic onco-surgeon, who operated on Binura.
He developed pain in the knee in July, 2014. "We noticed him limping and avoiding cricket, his favourtite sport. We consulted a local physician who prescribed him medicines for pain. But the pain didn't subside and a month later, we noticed swelling above his knee. An orthopaedic surgeon in Colombo suggested that this could be a tumour in his thigh bone and advised treatment in Bengaluru," says Mallikarachchige L R, Binura's father.
HOW DOES IT WORK
When the prosthesis is placed in the magnetic field, it leads to rotation of the magnetic disc at 16,000 rpm (revolutions per minute). The telescoping rod moves, resulting in expansion of the prosthesis. The tailor-made implant was imported from the UK to suit the unique specifications of Binura. This technique is tried only on paediatric cases with bone cancer.
Thursday, December 4, 2014
Caring for the Heart - Round-the-clock
Hyderabad: India is estimated to account for 60 per cent of heart disease patients worldwide. Heart diseases have emerged as the number one killer among Indians. What is more alarming is that many of the heart diseases occur late in the night or early in the morning.
Understanding the need of the hour, and accounting the rising trend of cardiac complications in patients, Aware Global Hospitals, L.B. Nagar has announced the launch of round-the-clock cardiac services.
“Global Hospitals, since inception has gained the reputation of pioneering and innovating many clinical programs. The growing incidence of cardiac problems and high level of complexities has made it imperative for us to further raise the benchmarks of our clinical programs significantly,” Dr. Vijay Vemuri, Chief Operating Officer, Aware Global Hospitals said while addressing the press conference.
“With the launch of the round-the-clock emergency services instead of a cardiology being on call we will now offer cardiology services 24X7 with cardiologists present. The team will also have a powerful confluence of cardiologists and cardiac Surgeons who will be supported by the most advanced technology and dedicated facilities, offering the most advanced treatments for simple to most complex cardiac problems,” Dr. Pramod Kumar Rao, Interventional Cardiologist, Aware Global Hospitals said.
“If a patient walks in with a cardiac problem which requires a percutaneous transluminal coronary angioplasty (PTCA) we can now do it within one hour as against the international bench mark of 90 minutes. Also 100 per cent occlusions can also be cleared at any point of time with 99.9 per cent success rate,” Dr Rao added.
According to Dr. Rao within the vicinity of the hospital in the last couple of months out of a sample size of around 100 cardiac patients treated at the hospital 70 per cent were men and the remaining 30 per cent females.
“Out of these 70 per cent men we treated around 50 per cent were senior citizens (above 65 years) and the rest were middle aged and youngsters. But the trend reversed in the case of women where only 30 per cent women were above the age of 65 years and a startling 70 per cent were either middle aged or young women,” he added.
ABOUT GLOBAL HOSPITALS GROUP, INDIA
Global Hospitals Group is one of the fast growing chains of multi super specialty tertiary care Hospitals in India offering healthcare services of international standards. With over 2000 beds, the Group currently has state-of the art and world class hospitals at Hyderabad, Chennai, Bangalore and Mumbai offering advanced patient care. With the most comprehensive multi-organ transplant services in the country, the Group has carved out a niche for itself by excelling in areas ranging from simple procedures to complex surgeries and multi-organ transplantation services for liver, kidneys, heart and lungs. It has evolved to become a one-stop healthcare destination for people from across the world. Recognized for internationally reputed doctors and cutting-edge medical technologies, the Group’s Hospitals have achieved several milestones by performing rare, pioneering surgeries and transplantations.
Friday, November 28, 2014
In a first-of-its-kind surgery, Global Health City successfully implants India’s 1st Artificial Lung Device
In a first-of-its-kind surgery, a 64-years old Bahraini woman with end-stage lung failure receives an implantable artificial lung as a bridge to transplant
Chennai, 25 November: Hopes of a 64-year old woman from Bahrain were kept alive at Global Health City with an implantable artificial lung, for the first time in India such a device had been used as a bridge to lung transplant. By introducing this new technology to India, Global Health City offers a glimmer of hope to thousands of patients with end-stage lung failure. With this innovative technology, the waiting time to receive a donor lung is extended.
Mrs. Fatima Mohammed Ahmed, underwent a lung transplant at Global Health City 3-years ago after her lung condition went bad due to Lymphangioleiomyomatosis (LAM) - a rare lung disease that tends to affect women in their child-bearing age. Post the transplant, she recovered well and returned to routine life within 2-months.
Things had been looking good and under control since then with regular follow-up and appropriate medication support. Unfortunately a year ago, she developed a fungal infection in her lungs, which led to Bronchiolotis Obliterans Syndrome (BOS) - a fibrotic process resulting in progressive narrowing of bronchiolar lumens and airflow obstruction, is a manifestation of chronic allograft rejection.
Having affected by BOS, Mrs. Fatima was prescribed with a series of medication regimes such as Anti BOS drugs, Immuno Suppressive Medications, etc. and the condition of her lung was closely monitored. Almost 10 months after she developed BOS and with medical management, her lung did not show any sign of improvement.
Dr. Vijil Rahulan – Senior Consultant Pulmonologist said, “Adding to her worries, her lung further deteriorated. She was in ventilator support and was not an eligible candidate for immediate lung transplant. Hence, we decided to postpone the surgery so that sufficient time is given for her to be ready to receive donor organ. Usually, people with end-stage lung failure are supported with a heart-lung bypass machine known as Extracorporeal Membrane Oxygenation (ECMO) that uses a pump and oxygenator to deliver oxygen to the vital organs. While ECMO can be successful for this purpose, it is a temporary solution. Extended use can pose serious health risks, including permanent organ damage and frequent bleeding; moreover it needs a continuous monitoring in ICU.”
“In the case of Mrs. Fatima, we had to offer the best possible support that buys her time to revive her condition and to wait for donor lung to become available. Considering the situation, our expert team decided to use Novalung, an Implantable Artificial Lung device. It is a pumpless device that needs minimal monitoring in the ICU and patient can be ambulated easily with the device in place which is not possible with ECMO”, pointed out by Dr. Rahul Chandola – Senior Consultant Heart & Lung Transplant Surgeon.
Commenting on the occasion, Dr. Govini Balasubramani – Senior Consultant Heart & Lung Transplant Surgeon said, “In India alone, about 1 lakh people were diagnosed with chronic end-stage lung diseases every year. Most of them succumb to death within 3 to 5 years even with appropriate medical management. Most importantly, 5 – 10% of them require immediate transplant in order to survive. Unfortunately, only about 17 such lung transplant surgeries were reported in India till date. The huge gap is primarily due to the non-availability of matching organ at the right time and a very minimal number of centres performing such a high end procedure. Novalung, as a bridge to transplant, supports the patient’s survival by extending the waiting-period to receive a donor organ up to 6 months.”
“I am very much thankful to the doctors at Global Health City for offering me another chance to live my life and to spend time with my family. When I came here with a failed lung condition, I and my family had a very little hope. Now with the artificial lung device implant, I am waiting to receive a donor lung and I am confident of starting a fresh lease of life again shortly”, said by Mrs. Fatima.
Highlighting the uniqueness of the procedure, Dr. Ashok Vardhan – Group COO of Global Hospitals added “Over the years, Global Health City has become a synonym to the most preferred organ transplant centre and is one of the largest multi-organ transplant centres in India. Adding to many first-of-its-kind transplant surgeries, today with India’s First Artificial Lung Device implant Global Health City has once again demonstrated its constant endeavor to offer the best possible treatment to patients by combining contemporary technology and processes.”
Novalung – An Implantable Artificial Lung Device
It is a breathing support system which is designed to support the exchange of gas in the lungs of the patient. The system removes carbon dioxide from incoming blood and Infuses oxygen into the blood thereby increasing oxygen levels. Clinical application of this device is indicated in the situations where strict application of lung-protective is performed and where there is insufficient exchange of gas, in particular insufficient removal of carbon dioxide.
Global Heart & Lung Institute
As one of Global Hospital’s cornerstone Centers of Excellence, Heart & Lung Institute is a premium, comprehensive center providing innovative, quality care close to home. Utilizing advanced medical and surgical equipment, the expert team of physicians and nurses practice evidence-based medicine blended with patient-centered care. From intervention to cardiothoracic surgery and rehabilitation, the institute’s approach hinges on personalized care, recognizing that every patient is unique.
23 year old Ganesan met with an accident, rushed to Global Health City with acute cardiac rupture; a high end complex heart surgery removed 2 liters of accumulated blood.
Chennai, 19th November 2014: Ganesan a 23 year’s old generally fit contract labourer, native of Salem met with an accident at a construction site and became unconscious. After first aid and due care, he was presented with critical heart injury. Investigations revealed an acute heart rupture and Temponade (compression of heart due to blood in the pericardial sac). Patient required an emergency open heart surgery to solve the acute rupture.
Open Heart Surgery: The Patient underwent an emergency surgery on 5th Nov. During the surgery around 2 litres of blood accumulated on the pericardial cavity was identified and his heart function was compromised due to severe cardiac Tamponade (compression of heart due to blood in the pericardial sac). As soon as surgeons opened the pericardium they sucked the blood with special blood recycle machine (Cell saver) and transfused the same to the patient again. After relieving the cardiac rupture measuring 3 cm at the left atrial and left pulmonary vein junction was repaired, and the patient survived the injury.
Speaking on the occasion Dr. Govini Balasubramani, Consultant – Cardio Thoracic surgeon, said “It is a difficult task to save a patient with acute cardiac rupture due to Chest wall Injury. Distension (swelling) of the neck vein, CT scan Chest and echocardiograms suggested cardiac tamponade (compression of heart due to blood in the pericardial sac), due to cardiac rupture. In patients surviving the initial insult, the overall mortality rate is 60%-90%. He was presented with a hypotension (low blood pressure), distension of neck veins, intact pericardium and cardiac tamponade. The diagnosis confirmed with emergent CT chest and echocardiography prior to operative intervention. Repair performed by median sternotomy (a kind of surgical procedure) and the potential necessity for cardiopulmonary bypass. We conclude rapid prehospital transportation, a high index of suspicion, and prompt surgical intervention contribute to survival in these patients. On this occasion I would like to thank my team of doctors, nurses and perfusionist and administrators who had helped in saving the patient’s life.”